Back to Portfolio

Redbiotec

Technology Platform to Develop Virus Envelopes
 
Redbiotec

Redbiotec provides a disruptive, patented technology platform to develop and produce "virus like particles" and other complex proteins. These particles enable big pharma to accelerate the development of novel vaccines against viral diseases such as pandemic flu, papilloma virus or seasonal influenza.


Homepage LinkedIn  Twitter